Search

Issue
Title
Authors
Skin microbiota in patients with psoriasis vulgaris and pustular psoriasis
Bakhlykova E.A., Filimonkova N.N., Timokhina T.K., Kurlovich N.A.
Psoriasis in pediatric dermatological clinical practice: diagnosis and management
Sidorenko O.A., Anisimova L.A., Starostenko V.V., Grebennikova S.V.
ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS
Sidorcika T.G., Linovs V.A., Radzina M.A., Rubins A.J., Rubins S.A.
Psoriasis incidence and prevalence in the Russian Federation
ZNAMENSKAYA L.F., MELEKHINA L.Y., BOGDANOVA Y.V., MINEYEVA A.A.
Features of skin colonization with Staphylococcus spp. in atopic dermatitis and psoriasis patients
Nikolaeva M.Y., Monakhov K.N., Sokolovskiy E.V.
Langerhans cells and gamma delta Т-lymphocytes in the pathogenesis of psoriasis
Sorokina E.V., Kalinichenko E.O., Bisheva I.V., Stolpnikova V.N.
Influence of ABCB1 3435C>T polymorphism on methotrexate safety in patients with psoriasis
Kubanov A.A., Asoskova A.V., Zastrozhin M.S., Sozaeva Z.A., Sychev D.A.
Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial
Puig L., Bakulev A.L., Kokhan M.M., Samtsov A.V., Khairutdinov V.R., Morozova M.A., Zolkin N.A., Kuryshev I.V., Petrov A.N., Artemeva A.V., Zinkina-Orikhan A.V.
Vulgar psoriasis and squamous cell carcinoma in a patient with discoid lupus erythematosus
Dubensky V.V., Nekrasova E.G., Alexandrova O.A., Muraveva E.S.
Treatment of patients suffering from psoriasis in cases of resistance to Infliximab
Butareva M.M., Znamenskaya L.F., Martynov A.A., BUTAREVA M.M., ZNAMENSKAYA L.F., MARTYNOV A.A.
Evaluation of the efficacy of introduction of a new medical technology fortreatment of chronic dermatoses based on the application of activated zincpyrithione
Kubanov A.A., Petrovsky F.I.
Results of the study of Cinocap cream clinical efficacy andsafety
Danilova A.A., Kosorukova I.M., Danilova A.A., Kosorukova I.M.
Possibility to use Ademetionine for the treatment of psoriaticpatients with a pathology of the hepatobiliary system
Matusevich S.L., Medvedeva I.V., Matusevich S.L., Medvedeva I.V.
Search for potential biomarkers of inveterate dermatoses by means of proteomic analysis
BRATSEVA Y.V., MOSHKOVSKY S.A., ZNAMENSKAYA L.F., KUBANOVA A.A., KUBANOV A.A.
Capabilities of the basic treatment preparations in the combined treatment of psoriasis
Hobeysh M.M., Monakhov K.N., Sokolovsky E.V.
Search for new molecular targets for anticytokine therapy of patients, suffering from the immune dependent skin disease — psoriasis
KUBANOV A.A., FRIGO N.V., ROTANOV S.V., HAYRULLIN R.F., ZNAMENSKAYA L.F., SVISHTCHENKO S.I.
Experience of treatment of psoriatic patients with monochromic ultraviolet light from excimer lamps in a combination with external drugs
NEMCHANINOVA O.B.
Melanocytic nevi in psoriasis patients: results of a study with the use of dermatoscopy
Sergeyeva I.G., Krinitsyna Y.M., Onipchenko V.V., Makarova N.G.
Distribution of melanocytes in the skin of psoriasis patients
Zhukov A.S., Khairutdinov V.R., Belousova I.E., Samtsov A.V.
Features of treatment of patients with psoriasis with metabolic syndrome
Khairutdinov V.R., Samtsov A.V.
Signaling Рathway Blockers: Action Mechanism, Efficacy, Safety of Therapy for Patients with Psoriasis and Psoriatic Arthritis
Bakulev A.A.
Methotrexate: Revisited efficiency and safety of drug administration in psoriasis patients
Bakulev A.L.
Anti-cytokine therapy of a patient suffering from psoriatic arthritis
Onipchenko V.V., Sergeeva I.G., Krinitsyina Y.M., Kondrashova A.A., Pahomova V.V., Hismatulina N.V.
Dynamics of expression rates of growth factor proteins in psoriatic patients receiving a phototherapy
Chikin V.V., Zhilova M.B., Smolyannikova V.A., Nefedova M.A.
Dermatovenereology in the Russian Federation: results of 2023
Kubanov A.A., Bogdanova E.V.
Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice
Bakulev A.L., Pritulo O.A., Kuntsevich Z.S., Khotko A.A., Yunovidova A.A., Gorognichev P.V., Ziganshin O.R., Rudneva N.S., Bildyuk E.V., Repina T.V., Dudko V.Y., Maksimova M.D.
The role of cells of the innate immune system in psoriasis
Sorokina E.V., Bisheva I.V.
Perspective trends of topical therapy of patients with psoriasis
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Targeted therapy of psoriasis: inhibition of the IL-23 signaling pathway — evidence from clinical studies and real practice
Hotko A.A., Pomazanova M.Y., Kruglova L.
Problems with differential diagnostics of seborrheic dermatitis and plaque psoriasis by the exampleof a particular case study
Samtsov A.V., SAMTSOV A.V.
Pro-inflammatory IL-1 and TNF alpha cytokines in affected skin foci in psoriatic patients
Katunina O.R., Rezaykina A.V., Katunina O.R., Rezaikina A.V.
Efficacy and safety of treatment of patients suffering from severe forms of psoriasis
BAKULEV A.L., KRAVCHENYA S.S., SLESARENKO N.A., SHABOGINA A.A.
Current clinical features in the course of psoriasis and psoriasiform states in children
MURASHKIN N.N., KUBANOVA A.A.
Assessment of the cytokine profile in psoriasis patients against the background of an immune-modulating therapy
OKHLOPKOV V.A., MEDVEDCHIKOV E.K., DOLGIKH T.I., PRAVDINA O.V., GORODILOV R.V., ZARAYEVA I.F.
Studying of relationship of Histocompatibility antigens and N-acetylation phenotype in patients of Uzbek populations with psoriasis
IBRAGIMOV S.I., MANSUROVA G.T., MAMATKULOV U.A., MAKHSUDOV M.R.
Role of CD11c-positive dendrite cells in the psoriasis pathogenesis
HAIRUTDINOV V.N.
Pharmacoeconomic aspects of treatment of psoriasis with biological drugs
Rudakova A.V., Kubanov A.A.
Profiles of patients with psoriasis for appointment gene-engineering biological therapy — clinical justification
Zhukov A.S., Khotko A.A., Khairutdinov V.R., Samtsov A.V.
Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor
Kungurov N.V., Zilberberg N.V., Kokhan M.M., Keniksfest J.V., Grishaeva E.V.
Psoriatic onychodystrophy: clinical manifestations (part 1)
Platonova A.V., Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I)
Namazova-Baranova L.S., Murashkin N.N., Ambarchyan E.T., Materikin A.I.
Selective intracellular inhibition of signalling pathways - new direction in systematic treatment of psoriasis patients
Bakulev A.L.
A case of psoriasiform syphilid (from clinical practice)
Koshkin S.V., Chermnykh T.V., Kovrova O.S., Ryabov N.Y.
Endothelial dysfunction and its treatment in psoriasis patients
Shtoda Y.M., Slesarenko N.A., Bakulev A.L., Utz S.R., Platonova A.N.
Search for predictors of psoriatic arthritis in patients with psoriasis
Artamonova O.G., Karamova A.E., Kubanov A.A., Verbenko D.A., Kozlova I.V.
Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
Bogdanova E.V.
Clinical evidence of therapy for genital psoriasis by biologic agents
Sokolovskiy E.V., Kokhan M.M.
Comparative study of anti-inflammatory activity of zinc pyrition on a psoriasis laboratory model
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Changes in the hormonal status of patients with focal psoriasis vulgaris
Vasil'ev A.G., Zaslavskiy D.V., Trashkov A.P., Kravtsova A.A., Kazikhanova S.R., Khayrutdinov V.R., Khvedelidze M.G., VASILIYEV A.G., ZASLAVSKY D.V., TRASHKOV A.P., KRAVTSOVA A.A., KAZIKHANOVA S.R., KHAIRUTDINOV V.R., KHVEDELIDZE M.G.
Affected skin examination in psoriatic patients in the courseof Infliximab therapy (a morphologic analysis)
Katunina O.R., Znamenskaya L.F., Matushevskaya Y.I., Katunina O.R., Znamenskaya L.F., Matushevskaya Y.I.
Role of recognizing receptors in the initiation of immune inflammation in theskin of psoriasis patients
Katunina O.R., Rezaikina A.V., Kolykhalova O.I.
Functions of Toll-like receptors as an inborn immunity component and their participation in the pathogenesis of dermatoses of different etiologies
KATUNINA O.R.
Intestinal helminth and protozoan infections in patients withchronic dermatoses
Gerasimova N.A., Kokhan M.M., Belykh O.A., Keniksfest Y.V., Gerasimova N.A., Kokhan M.M., Belykh O.A., Keniksfest Y.V.
Currentaspects of psoriasis phototherapy
Zhilova M.B., Butareva M.M., Volnukhin V.A., Zhilova M.B., Butareva M.M., Volnukhin V.A.
TLR - possible molecular target for biologic psoriasis therapy
Katunina O.R., Rezaykina A.V.
Rational external therapy of scalp psoriasis
Perlamutrov Y.N., Olkhovskaya K.B.
Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade
Chikin V.V.
Studying of the interleukin-36γ expression level in the skin of patients with plaque psoriasis
Pashkin A.Y., Zhukov A.S., Khairutdinov V.R., Belousova I.E., Samtsov A.V., Garabagiou A.V.
Systemic Psoriasis Treatment at an Early Age (Part II): Issues of Biological Therapy
Namazova-Baranova L.S., Murashkin N.N., Ambarchian E.T., Materikin A.I.
Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis
Samtsov A.V., Khairutdinov V.R., Bakulev A.L., Kubanov A.A., Karamova A.E., Artem’eva A.V., Korotaeva T.V.
Chronic inflammation, insulin resistance, psoriasis - which have in common?
Rasin M.S.
Influence of natural factors Saki lake combined with “Berlition® 600” (Thioctic acidi) on immunoregulatory processes taking into account morphological changes of skin in patients with plaque psoriasis
Kuznetsova M.Y., Pritulo O.A., Prokhorov D.V.
Personalization of an anti-cytokine therapy of psoriatic patients
Kubanov A.A., Svishchenko S.I.
Features of psoriasis treatment with infection COVID-19
Tashkenbaeva U.A., Aliev A.S., Usmanaliev S.A.
Predictive model and classification for psoriatic arthritis risk assessment for Russian patients with psoriasis (on registry data)
Bogdanova E.V.
The age at first cutaneous manifestation of psoriasis as a prognostic factor in the timing of psoriatic arthritis diagnosis
Bogdanova E.V.
Epidemiology of psoriasis in the Russian Federation according to the patient registry
Kubanov A.A., Bogdanova E.V.
The Actual Challenges of Biologics Treatment in Patients with Psoriasis
Bakulev A.L.
The role of T-regulatory cells in the pathogenesis of psoriasis
Khayrutdinov V.R., Mikhaylichenko A.F., Mukhina M.S., Samtsov A.V., Imyanitov E.N., Ivanov A.M., KHAIRUTDINOV V.R., MICHAILICHENCO A.F., MUKHINA M.A., SAMTSOV A.V., IMYANITOV E.N., IVANOV A.M.
Genetic profile of psoriasis patients
Khayrutdinov V.R., Khairutdinov V.R.
Personalized approach to the selection of therapy for patients with psoriasisbased on the results of molecular and genetic tests
Znamenskaya L.F., Frigo N.V., Rotanov S.V., Volkov I.A., Volnukhin V.A., Zhilova M.B.
Combination treatment of psoriasis patients with kartalinointment and ehf therapy
Dmitruk V.S., Dmitruk V.S.
Inhibitors of tumor necrosis factor-alpha for treatment ofpsoriatic patients
Znamenskaya L.F., Znamenskaya L.F.
Molecular Markers In Forecasting The Clinical Efficacy Of Infliximab In Psoriasis Patients
KUBANOVA A.A., LESNAYA I.N., FRIGO N.V., KAGANOVA N.L., ZNAMENSKAYA L.F., KUBANOV A.A.
Current topical therapy of psoriatic patients suffering from scalp lesions
FILIMONKOVA N.N., TOPYCHKANOVA Y.P.
Results of a study of genetic factors predisposing to the development of psoriasis among the population of the Russian Federation
MINEYEVA A.A., KOZHUSHNAYA O.S., ZNAMENSKAYA L.F., CHIKIN V.V., FRIGO N.V.
Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis
Olisova O.Y., Svistunova D.A., Chernyavskaya L.M., Anpilogova E.M.
Influence of focal infection on the immune status of psoriasis patients
Patrushev A.V., Samtsov A.V., Nikitin V.Y., Sukharev A.V., Ivanov A.M., Gumilevskaya O.P., Sukhina I.A.
Psoriasis: clinical and epidemiological features and therapy issues
Bakulev A.L., Fitileva T.V., Novodezerkina E.А., Gilloteau I., Tian Н., Howe T., Pietri G.
ASSOCIATED PATHOLOGY: CLINICAL ОBSERVATION
Tlish M.M., Popovskayа E.B., Sycheva N.L., Sorokina N.V., Psavok F.A.
Strategy “treat to target” for patients with psoriasis. Relevant issues to biological therapy persistence
Bakulev A.L.
ISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS IN PATIENT SUFFERING FROM PLAQUE PSORIASIS: A CASE REPORT
Znamenskaya L.F., Chikin V.V., Kappusheva I.A., Kondrasheva V.V.
Inflammation and itching in patients suffering from atopic dermatitis and psoriasis. Assessment of the expression of neurotrophins аnd neuropeptides
Smolyannikova V.A., Kubanova A.A., Chikin V.V., Karamova A.E.
Comparative evaluation of the effectiveness of balneotherapy and balneotherapy in combination with intravenous laser irradiation of blood at the period of spa treatment of patients with psoriasis
Sadovskaya E.A., Gorlova N.A., Sherengovskaya Y.V., Pritulo O.A., Prokhorov D.V., Ravlyuk D.A., Gumenyuk L.N.
Resources and performance rates of medical organizations providing medical care in the field of dermatovenereology in the Russian Federation in 2016–2022
Kubanov A.A., Bogdanova E.V.
Efficacy and safety of treatment of moderate and severe psoriasis with the interleukin 23 inhibitor risankizumab
Bakulev A.L., Kruglova L.S.
The new external drug for the treatment of psoriasis based on inhibition of serine proteases
Zhukov A.S., Zharun E.R., Khairutdinov V.R., Samtsov A.V., Krasavin M.Y., Garabagiou A.V.
Assessment of CLA+T-cell subpopulations in the blood of patients with chronic dermatoses
Patrushev A.V., Samtsov A.V., Nikitin V.Y., Soukharev A.V., Gumilevskaya O.P., Sukhina I.A.
Immunohistochemical analysis of molecular cell structures of genetic and adaptive immunityin patients suffering from psoriasis in the course of biological therapy
Katunina O.R., KATUNINA O.R.
Clobetasol propionate (Dermovate) gives new opportunities in the treatment ofdermatoses
Khlebnikova A.N.
Assessment of the clinical efficacy of the administration of Phosphogliv in complex treatment of psoriasis patients
Orlov Y.V., Konnov P.Y., Kotelnikova Y.V.
Clinical, molecular and genetic studies of efficacy and safety of using UV irradiation for psoriasis patients
Zhilova M.B., Kubanov A.A., Lesnaya I.N., Frigo N.V., Volkov I.A., Znamenskaya L.F., Volnukhin V.A.
Administering hepatoprotectors for psoriasis: a comparative clinical, laboratory and ultrasonic assessment of its efficacy
BAKULEV A.L., KRAVCHENYA S.S.
Biological therapy of patients with severe psoriasis
NV KUNGUROV M.K., KENICKSFEST Y.V., Keniksfest Y.V.
Study of the genetic factors predisposing to the development of psoriasis
MINEEVA A.A., KOZHUSHNAYA O.S., VOLNUKHIN V.A., FRIGO N.V., ZNAMENSKAYA L.F., KUBANOV A.A., MELEKHINA L.E.
Pathogenic value of neuropeptides and growth factor proteins for the development of inflammation and itching in patients with prevalent dermatoses
CHIKIN V.V., ROTANOV S.V., KHAIRULLIN R.F., ZNAMENSKAYA L.F., VAKHITOVA I.I., INOYATOVA L.A.
Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext
Bakulev A.L., Samtsov A.V., Kubanov A.A., Khairutdinov V.R., Kokhan M.M., Artemyeva A.V., Derbin S.I., Chernyaeva E.V., Ivanov R.A.
Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis
Kubanov A.A., Bakulev A.L., Samtsov A.V., Khairutdinov V.R., Sokolovskiy E.V., Kokhan M.M., Artemyeva A.V., Chernyaeva E.V., Ivanov R.A.
Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for the treatment of patients suffering from psoriasis
Bakulev A.L.
ACRODERMATITIS CONTINUA SUPPURATIVA HALLOPEAU IN COMBINATION WITH LOCALIZED PSORIASIS VULGARIS
Sokolovskiy E.V., Mikheev G.N.,  Gordeeva A.A.
Using clobetasol propionate in the form of a shampoo for the treatment of patients suffering from psoriasis localized in the scalp area
Bakulev A.L., Kravchenya S.S., Igonina I.A., Utz S.R.
A case of generalized pustular psoriasis
Oklopkov V.A., Pravdina O.V., Chermoschentsev A.A., Repina T.V., Poleshuk E.I., Gudoshnik V.G., Gorodilov R.V.
Prevalence of genetic risk factors of psoriasis among the population of the Russian Federation
Kubanov A.A., Kubanova A.A., Karamova A.E., Mineyeva A.A.
Experience of using genetic engineering biological therapy in a patient with psoriasis and chronic renal failure under hemodialysis
Kulakova E.V., Rybalkin S.B.
A prospective open-label study of the antifungal activity of external forms of activated zinc pyrithione in the treatment of Malassezia-associated skin diseases
Samtsov A.V., Patrushev A.V., Chepushtanova K.O., Bogdanova T.V., Alekssev A.Y., Bogomolova T.S., Vasilyeva N.V.
Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial
Bakulev A.I., Samtsov A.V., Sokolovskiy E.V., Kokhan M.M., Khobeish M.M., Khairutdinov V.R., Karamova A.E., Olisova O.U., Ignatiev D.V., Nikiforova A.N., Artemeva A.V., Zinkina-Orikhan A.V.
Disorders of the skin microbiome in atopic dermatitis and psoriasis
Nikolaeva M.Y., Monakhov K.N., Sokolovskiy E.V.
Systemic treatment of psoriasis: from methotrexate to biologics
Olisova O.Y., Anpilogova E.M.
Association of polymorphism of IL12B gene and predisposition to psoriasis among the populationof the Northwestern region of Russia
Khayrutdinov V.R., Mikhaylichenko A.F., Piskunova A.A., Samtsov A.V., Ivanov A.M., Imyanitov E.N., KHAIRUTDINOV V.R., MIKHAILICHENKO A.F., PISKUNOVA A.A., SAMTSOV A.V., IVANOV A.M., IMYANITOV Y.N.
Proteome technologies in studying the pathogenesisof psoriasis
Znamenskaya L.F., Znamenskaya L.F.
Possibilities of enhancement of the efficiency of complex psoriasis treatment
VLADIMIROVA I.S., MONAKHOV K.N.
The genetic factors in aetiology and pathogenesis of psoriasis
Kungurov N.V., Filimonkova N.N., Golubtsov V.I., Korkhmazova S.A.
A study of the efficacy of using the Kartalin ointment in a complex with exogenous melatonin for psoriasis
DMITRUK V.S., MARTYNOVA V.G., KAMYSHNIKOVA O.A., DMITRUK S.I.
Use of Skin-Cap (activated zinc pyrithione) in the therapy of chronic dermatoses
Current approaches to the external therapy of psoriasis
KHLEBNIKOVA A.N.
Scalp psoriasis: new potential of the topical therapy
Bakulev A.L., Kravchenya S.S.
Precision therapy for psoriasis patients
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Effectiveness of resuming ustekinumab therapy in psoriasis patients with metabolic disorders. Clinical experience
Rychkova I.V., Prytulo O.A.
Prevalence of chronic infection foci in patients with dermatoses
Patrushev A.V., Samtsov A.V., Ivanov A.M., Sukharev A.V., Asfendiarov D.D.
Efficacy of the combined therapy with etanercept and methotrexat at the female patient with generalized pustular psoriasis and arthritis psoriasis after the therapeutic failure of two the TNF-α receptor inhibitors. Case study
Vustina V.V., Grigoriadi N.E., Korotayeva T.V.
Immune pathogenesis of psoriasis
Khairutdinov V.R., Belousova I.E., Samtsov A.V.
Particular features of lipid metabolism in psoriasis patients with concomitant metabolic syndrome
Pashinyan A.G., Dontsova Y.V.
Blood cytokines as potential predictors of therapy effectiveness in patients with moderate to severe psoriasis treated with the IL-12/IL-23 inhibitor ustekinumab
Karamova A.E., Vorontsova A.A., Nikonorov A.А., Nikonorova E.R., Kubanov А.A.
The role of exosomes in the diagnostics and treatment of immune mediated skin disoders, wounds and alopecia
Palkina N.V., Zenaishvili R.D., Ruksha T.G.
Periods till psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis (according to psoriasis patient registry)
Kubanov A.A., Bogdanova E.V.
Experience of using ustekinumab in the treatment of a patient with HIV-associated psoriasis and anogenital warts
Babkova M.I., Arshinsky M.I., Frolova Z.V., Chudina O.A., Mitrofanova J.S., Batalova S.K.
Revisiting the question of psoriasis classification
Karamova A.E., Olisova O.Y., Bakulev A.L., Kokhan M.M., Khairutdinov V.R., Sokolovskiy E.V., Khobeych M.M.
Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19
Kubanov A.A., Bakulev A.L., Kokhan M.M., Olisova O.Y., Samtsov A.V., Sokolovskiy E.V., Khairutdinov V.R., Khobeish M.M.
Markers of efficacy of Infliximab in psoriasis patients
Kubanova A.A., Znamenskaya L.F., Frigo N.V., Volkov I.A., Rotanov S.V., Rezaykina A.V., KUBANOVA A.A., ZNAMENSKAYA L.F., FRIGO N.V., VOLKOV I.A., ROTANOV S.V., REZAIKINA A.V.
The experience of treatment for palmar and plantar psoriasis
Togoeva L.S., Minnibaeva M.T., Lukiyanova E.N., Korsunskaya I.M.
A case study: combination of pemphigus foliaceus and psoriasis. Problems of diagnostics
NADGERIYEVA O.V., ZNAMENSKAYA L.F., AVDIYENKO I.N., KATUNINA O.R., MURUZOVA I.V.
Mechanism of the biological effect of the tumor necrosis factor-аlpha at psoriasis
ZNAMENSKAYA L.F., YEGOROVA Y.Y., ZITNER S.V.
On the efficiency and safety of application of the short course of clobetasol propionate at patients, suffering from psoriasis in the progression phase
BAKULEV A.L., KRAVHCHENYA S.S.
Immune mechanisms of psoriasis. New strategies of biotherapy
KUBANOVA A.A., KUBANOV A.A., NIKOLAS J.F., PUIG L., PRINCE J., KATUNINA O.R., ZNAMENSKAYA L.F.
Study of the genetic factors predisposing to the development of psoriasis
LVOV A.N., KATUNINA O.R., ZNAMENSKAYA L.F., MICHENKO A.V., EGOROVA Y.Y., INOYATOVA L.A., HAIRULLIN R.F., VOLKOV I.A.
Association of polymorphisms in TNFAIP3 and TNIPI genes with predisposition to the development of psoriasis in the Russian population
KUBANOV A.A., KOZHUSHNAYA O.S., FRIGO N.V., MINEYEVA A.A., ZNAMENSKAYA L.F., CHIKIN V.V.
Results of the long-term observational noninterventional prospective study BODYGUARD in psoriasis patients
Bakulev A.L., Petrunin D.D.
Indices of peroxidation of lipids of biological membranes and endogenous intoxication in patients with psoriasis on the background of chronic viral hepatitis С
Marzhokhova M.Y., Hussein A., Marzhokhova A.R.
Analysis of methods common topical treatment of the generalized dermatoses in the delivery of the specialized health care in the profile "Dermatology"
Kokhan M.M., Samtsov A.V., Perlamutrov Y.N., Sokolovskiy E.V.
The role of bacterial infection in the pathogenesis of psoriasis
Slesarenko N.A., Utz S.R.
Psoriasis and porphyria cutanea tarda, associated with chronic hepatitis C in HIV-infected patients (clinical observation)
Korotaeva I.A., Sklyar L.F., Simakova A.I., Singur L.G., Popov A.F.
Pathogenic aspects of treatment of psoriatic patients
Chikin V.V., Znamenskaya L.F., Mineyeva A.A.
Systemic therapy of psoriasis and psoriatic arthritis: assignment algorithms
Khobeysh M.M., Sokolovskiy E.V.
Anticytokine therapy with interleukin-17 in patients with moderate and severe psoriasis
Kovaleva J.S., Kazantsev I.V., Aibazova A.A., Ovchinnikova E.O., Garina A.A., Shabaldina A.P.
Comprehensive assessment of the dynamics of angiogenesis in patients with psoriasis treated with methotrexate
Pritulo O.A., Petrov A.A.
The peripheral blood regulatory T-cells analysis as a criterion for assessing the therapy efficacy and a prognostic marker for the duration of remission of psoriasis
Olisova O.Y., Gudova V.V.
Features of the cytokine profile and the effectiveness of radical treatment of focal infection in patients with psoriasis
Patrushev A.V., Samtsov A.V., Soukharev A.V.
Emollient and keratolytic agens in the complex treatment of psoriasis
Korsunskaya I.M., Togoeva L.S., Bagaeva M.I., Luk'yanova E.N., KORSUNSKAYA I.M., TOGOYEVA L.S., BAGAYEVA M.I., LUKIYANOVA Y.N.
Psoriatic arthritis: particular features of its clinical course
Martynov A.A., Znamenskaya L.F., Butareva M.M., Kappusheva I.A., Popov D.V., Martynov A.A., Znamenskaya L.F., Butareva M.M., Kappusheva I.A., Popov D.V.
Efficacy of repeated treatment courses of lactulose as a component of complex therapy in patients with psoriasis
Matusevich S.L., Medvedeva I.V.
1 - 150 of 162 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».